GGrantIndex
← Leaderboards

G. William Rebeck

Georgetown University

$14,030,662
Attributed
$14,503,919
Total exposure
12
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.5M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$14,503,919 · 12

By mechanism

R01$9,468,638 · 4
T32$3,080,990 · 2
P01$1,109,424 · 1
R21$429,000 · 1
R03$290,450 · 3
R29$125,417 · 1

Top collaborators

Most similar at Georgetown University

Same institution · by research overlap

Others in their field

Top investigators on “Alzheimer&Apos

Research focus

Alzheimer&AposNeuronsS DiseaseIn VivoAffectProtein IsoformsBrainS Disease RiskAgingInflammationGenotypeApolipoprotein ELearningLdl-Receptor Related Protein 1Genetic Risk FactorMouse ModelStructureAstrocytesPreventSynapsesBehaviorProteinsBaseIn Vitro

Grant awards (53)

Aging and Alzheimer's Research Training$364,884
T32 · FY2025 · AG · contact PI
Aging and Alzheimer's Research Training$532,797
T32 · FY2024 · AG · contact PI
APOE4 promotes pathogenesis in a mouse model of cancer chemotherapy-induced cognitive impairment$386,920
R01 · FY2024 · AG · contact PI
Aging and Alzheimer's Research Training$502,808
T32 · FY2023 · AG · contact PI
APOE4 promotes pathogenesis in a mouse model of cancer chemotherapy-induced cognitive impairment$386,920
R01 · FY2023 · AG · contact PI
APOE4 promotes pathogenesis in a mouse model of cancer chemotherapy-induced cognitive impairment$28,428
R01 · FY2023 · AG · contact PI
Aging and Alzheimer's Research Training$515,931
T32 · FY2022 · AG · contact PI
APOE4 promotes pathogenesis in a mouse model of cancer chemotherapy-induced cognitive impairment$386,920
R01 · FY2022 · AG · contact PI
Synergistic effect of APOE genotype and obesity in CNS inflammation and risk of Alzheimer's disease$195,000
R21 · FY2022 · AG · contact PI
Predoctoral Training in Integrative Neuroscience$171,700
T32 · FY2022 · NS
APOE4 promotes pathogenesis in a mouse model of cancer chemotherapy-induced cognitive impairment$68,228
R01 · FY2022 · AG · contact PI
APOE4 promotes pathogenesis in a mouse model of cancer chemotherapy-induced cognitive impairment$386,920
R01 · FY2021 · AG · contact PI
APOE isoform affects protein structure and function in normal brain$385,698
R01 · FY2021 · NS · contact PI
Synergistic effect of APOE genotype and obesity in CNS inflammation and risk of Alzheimer's disease$234,000
R21 · FY2021 · AG · contact PI
Aging and Alzheimer's Research Training$218,055
T32 · FY2021 · AG · contact PI
Predoctoral Training in Integrative Neuroscience$196,996
T32 · FY2021 · NS
APOE4 promotes pathogenesis in a mouse model of cancer chemotherapy-induced cognitive impairment$39,799
R01 · FY2021 · AG · contact PI
APOE isoform affects protein structure and function in normal brain$391,096
R01 · FY2020 · NS · contact PI
APOE4 promotes pathogenesis in a mouse model of cancer chemotherapy-induced cognitive impairment$386,716
R01 · FY2020 · AG · contact PI
Predoctoral Training in Integrative Neuroscience$194,766
T32 · FY2020 · NS
APOE isoform affects protein structure and function in normal brain$450,468
R01 · FY2019 · NS · contact PI
Predoctoral Training in Integrative Neuroscience$192,589
T32 · FY2019 · NS
APOE isoform affects protein structure and function in normal brain$385,698
R01 · FY2018 · NS · contact PI
Predoctoral Training in Integrative Neuroscience$190,464
T32 · FY2018 · NS
APOE isoform affects protein structure and function in normal brain$59,372
R01 · FY2018 · NS · contact PI
APOE isoform affects protein structure and function in normal brain$337,486
R01 · FY2017 · NS · contact PI
ApOE effects on neuron signaling and function via ApoER2$504,003
R01 · FY2014 · AG · contact PI
ApOE effects on neuron signaling and function via ApoER2$479,477
R01 · FY2013 · AG · contact PI
TRAFFICKING, SHREDDING, AND FUNCTIONS OF APOER2$206,457
P01 · FY2013 · AG · contact PI
Molecular actions of VLDLR in dendritic spine formation$73,474
R03 · FY2013 · AG · contact PI
ApOE effects on neuron signaling and function via ApoER2$569,769
R01 · FY2012 · AG · contact PI
TRAFFICKING, SHREDDING, AND FUNCTIONS OF APOER2$218,473
P01 · FY2012 · AG · contact PI
ApOE effects on neuron signaling and function via ApoER2$507,784
R01 · FY2011 · AG · contact PI
TRAFFICKING, SHREDDING, AND FUNCTIONS OF APOER2$225,757
P01 · FY2011 · AG · contact PI
ApOE effects on neuron signaling and function via ApoER2$57,730
R01 · FY2011 · AG · contact PI
ApOE effects on neuron signaling and function via ApoER2$545,296
R01 · FY2010 · AG · contact PI
Apolipoprotein E receptors and Alzheimers disease$273,043
R01 · FY2010 · AG · contact PI
TRAFFICKING, SHREDDING, AND FUNCTIONS OF APOER2$228,072
P01 · FY2010 · AG · contact PI
Apolipoprotein E receptors and Alzheimers disease$275,802
R01 · FY2009 · AG · contact PI
TRAFFICKING, SHREDDING, AND FUNCTIONS OF APOER2$230,665
P01 · FY2009 · AG · contact PI
Fyn modulation of APP processing$65,238
R03 · FY2009 · AG · contact PI
Apolipoprotein E receptors and Alzheimers disease$275,802
R01 · FY2008 · AG · contact PI
Fyn modulation of APP processing$65,238
R03 · FY2008 · AG · contact PI
Apolipoprotein E receptors and Alzheimers disease$281,431
R01 · FY2007 · AG · contact PI
Apolipoprotein E receptors and Alzheimers disease$289,836
R01 · FY2006 · AG · contact PI
Functions of Lipoprotein Receptors in Alzheimer Disease$301,088
R01 · FY2005 · AG
Functions of Lipoprotein Receptors in Alzheimer Disease$301,088
R01 · FY2004 · AG
Functions of Lipoprotein Receptors in Alzheimer Disease$50,842
R01 · FY2004 · AG
Functions of Lipoprotein Receptors in Alzheimer Disease$12,250
R01 · FY2004 · AG
Functions of Lipoprotein Receptors in Alzheimer Disease$301,088
R01 · FY2003 · AG
Functions of Lipoprotein Receptors in Alzheimer Disease$361,640
R01 · FY2002 · AG
Novel A-beta mutation associated with familial CAA$86,500
R03 · FY2001 · AG
APOE AND ITS RECEPTORS IN NORMAL AND ALZHEIMERS BRAIN$125,417
R29 · FY2000 · AG